Pen Needles Market Size is valued at USD 1.66 Bn in 2024 and is predicted to reach USD 3.43 Bn by the year 2031 at a 10.95% CAGR during the forecast period for 2024-2031.
Pen needle devices are available in a variety of lengths to fit different depths of subcutaneous tissue beneath the skin's surface. Pen needles are intended for single-use subcutaneous injection of medication and should not be reused. Diabetes is becoming more common, which has increased the demand for pen needles. With the expanding diabetic population, the target market is likely to increase at a rapid pace over the forecast period. Diabetic patients regularly utilize pen injectors to inject insulin or other medications. Obesity is among the major factors for diabetes, accounting for 80-85% of the chance of having the disease, according to Diabetes.co.uk. Insulin pens are the most simple and quick way to administer the medicine. Pen needles are in huge demand, in tandem with the increased need for insulin pens for diabetics.
Technological advances in various product kinds are also expected to support the growth of the pen needles business. Companies are concentrating on new product development in terms of needle length. For example, in 2021, BD (Becton, Dickinson, and Company) introduced the BD Nano Ultra-Fine pen needle, which has a needle length of 4 mm for increased patient comfort and consistent insulin delivery.
The Pen Needles market has been segmented based on time, length, therapy, and mode of purchase. The market is segmented as standard pen needles and safety pen needles based on type. The length segment includes 4 mm, 5 mm, 6mm, 8mm, and 10 mm. The therapy segment includes insulin, GLP 1, growth hormone, and other therapies. By the mode of purchase, the market is bifurcated as retail and non-retail.
Since diabetes individuals use bigger dosages daily, standard pen needles were recognized as the largest category. These needles are used by patients having dexterity issues. However, because there is a considerable danger of creating needlestick injuries, which restricts the safe applicability of pen needles, demand for these needles is expected to fall over the projection period.
The 8mm pen needle accounted for a sizable market share. These needles are most usually recommended to all patients, including those who are overweight and have the target condition. It provides benefits such as security, user convenience, and ease of disposal.
Due to the increasing frequency of the target condition in this region, Europe dominated the market. Furthermore, the government of the United Kingdom is taking majors to invest in diabetes care & research to improve treatment procedures for diabetic people. The growing number of diabetes patients in this region is fundamentally driving market growth in the United Kingdom. Diabetes, for example, affects more than 4.3 Bn individuals in the United Kingdom, according to Diabetes UK. Furthermore, 850,000 people with diabetes may go undetected.
| Report Attribute | Specifications |
| Market Size Value In 2024 | USD 1.66 Bn |
| Revenue Forecast In 2031 | USD 3.43 Bn |
| Growth Rate CAGR | CAGR of 10.95% from 2024 to 2031 |
| Quantitative Units | Representation of revenue in US$ Bn and CAGR from 2024 to 2031 |
| Historic Year | 2019 to 2023 |
| Forecast Year | 2024-2031 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Product, Technology, Application, End-User |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
| Competitive Landscape | Becton, Dickinson and Company (US), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), B. Braun Melsungen AG (Germany), Owen Mumford (UK), Terumo Corporation (Japan), Nipro Corporation (Japan) Allison Medical (US), AdvaCare Pharma (US), Berpu Medical Technology (China), ARKRAY (Japan), GlucoRx (UK), HTL-STREFA (Poland), UltiMed, (US), Hindustan Syringes and Medical Devices (India), Artsana Group (Italy), PromiseMed Diabetes Care (Canada), Montmed (Canada), Trividia Health (US), VOGT Medical Vertrieb (Germany), Van Heek Medical (Netherlands), Simple Diagnostics (US), Lyon (Turkey), Links Medical Products (US), and MHC Medical Products (US). |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Pen Needles Market By Type-
Pen Needles Market By Length-
Pen Needles Market By Mode of Purchase-
Pen Needles Market By Therapy-
Pen Needles Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.